{
    "balance": {
        "data": [
            "CONSOLIDATED BALANCE SHEETS\tDollars in Millions, Except Share and Per Share Data\tDecember 31,\tASSETS\t2018\t2017\tCurrent Assets:\tCash and cash equivalents\t$\t6,911\t$\t5,421\tMarketable securities\t1,973\t1,391\tReceivables\t5,965\t6,300\tInventories\t1,195\t1,166\tPrepaid expenses and other\t1,116\t576\tTotal Current Assets\t17,160\t14,854\tProperty, plant and equipment\t5,027\t5,001\tGoodwill\t6,538\t6,863\tOther intangible assets\t1,091\t1,210\tDeferred income taxes\t1,371\t1,610\tMarketable securities\t1,775\t2,480\tOther assets\t2,024\t1,533\tTotal Assets\t$\t34,986\t$\t33,551\tLIABILITIES\tCurrent Liabilities:\tShort-term debt obligations\t$\t1,703\t$\t987\tAccounts payable\t1,892\t2,248\tAccrued liabilities\t6,489\t6,014\tDeferred income\t172\t83\tIncome taxes payable\t398\t231\tTotal Current Liabilities\t10,654\t9,563\tDeferred income\t468\t454\tIncome taxes payable\t3,043\t3,548\tPension and other liabilities\t1,048\t1,164\tLong-term debt\t5,646\t6,975\tTotal Liabilities\t20,859\t21,704\tCommitments and contingencies\tEQUITY\tBristol-Myers Squibb Company Shareholders  Equity:\tPreferred stock, $2 convertible series, par value $1 per share: Authorized 10 million shares; issued and outstanding 3,590 in 2018 and 4,070 in 2017, liquidation value of $50 per share\t \t \tCommon stock, par value of $0.10 per share: Authorized 4.5 billion shares; 2.2 billion issued in both 2018 and 2017\t221\t221\tCapital in excess of par value of stock\t2,081\t1,898\tAccumulated other comprehensive loss\t(2,762\t)\t(2,289\t)\tRetained earnings\t34,065\t31,160\tLess cost of treasury stock   576 million common shares in 2018 and 575 million common shares in 2017\t(19,574\t)\t(19,249\t)\tTotal Bristol-Myers Squibb Company Shareholders' Equity\t14,031\t11,741\tNoncontrolling interest\t96\t106\tTotal Equity\t14,127\t11,847\tTotal Liabilities and Equity\t$\t34,986\t$\t33,551\tThe accompanying notes are an integral part of these consolidated financial statements.\t56\tBRISTOL-MYERS SQUIBB COMPANY\tCONSOLIDATED STATEMENTS OF CASH FLOWS\tDollars in Millions\tYear Ended December 31,\t2018\t2017\t2016\tCash Flows From Operating Activities:\tNet earnings\t$\t4,947\t$\t975\t$\t4,507\tAdjustments to reconcile net earnings to net cash provided by operating activities:\tDepreciation and amortization, net\t637\t789\t382\tDeferred income taxes\t86\t1,010\t(204\t)\tStock-based compensation\t221\t199\t205\tImpairment charges\t126\t327\t63\tPension settlements and amortization\t186\t236\t169\tDivestiture gains and royalties\t(992\t)\t(706\t)\t(1,187\t)\tAsset acquisition charges\t85\t760\t274\tLoss/(gain) on equity investments\t512\t(23\t)\t37\tOther adjustments\t(44\t)\t120\t(36\t)\tChanges in operating assets and liabilities:\tReceivables\t(429\t)\t(431\t)\t(803\t)\tInventories\t(216\t)\t(29\t)\t(152\t)\tAccounts payable\t(59\t)\t320\t104\tDeferred income\t84\t(642\t)\t(64\t)\tIncome taxes payable\t162\t2,597\t(453\t)\tOther\t634\t(227\t)\t216\tNet Cash Provided by Operating Activities\t5,940\t5,275\t3,058\tCash Flows From Investing Activities:\tSale and maturities of marketable securities\t2,379\t6,412\t4,809\tPurchase of marketable securities\t(2,305\t)\t(5,437\t)\t(3,089\t)\tCapital expenditures\t(951\t)\t(1"
        ],
        "timestamp": "2025-01-21_09-31-44"
    }
}